Role of leucine-rich α-2-glycoprotein in Taiwanese patients with inflammatory bowel disease as a predictive biomarker for endoscopic activity

Figure 1 Diagnostic probability of leucine-rich α-2-glycoprotein, C-reactive protein, and fecal calprotectin for detecting active endoscopic disease in patients with inflammatory bowel disease, ulcerative colitis, and Crohn’s disease. A: In patients with inflammatory bowel disease; B: In patients with ulcerative colitis; C: In patients with Crohn’s disease. IBD: Inflammatory bowel disease; FC: Fecal calprotectin; AUC: Area under the curve; LRG: Leucine-rich α-2-glycoprotein; CRP: C-reactive protein; AUROC: Area under the receiver operating characteristic curve; UC: Ulcerative colitis; CD: Crohn’s disease.